mRNA |
dabrafenib |
GDSC1000 |
pan-cancer |
AAC |
-0.096 |
0.001 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.001 |
mRNA |
ELCPK |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.002 |
mRNA |
parbendazole |
CTRPv2 |
pan-cancer |
AAC |
0.094 |
0.002 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.099 |
0.002 |
mRNA |
LE-135 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.003 |
mRNA |
AT-7519 |
GDSC1000 |
pan-cancer |
AAC |
0.086 |
0.003 |
mRNA |
nakiterpiosin |
CTRPv2 |
pan-cancer |
AAC |
0.096 |
0.003 |
mRNA |
rigosertib |
CTRPv2 |
pan-cancer |
AAC |
0.094 |
0.004 |
mRNA |
GSK461364 |
CTRPv2 |
pan-cancer |
AAC |
0.089 |
0.004 |